Organ-on-a-chip Market Analysis by Offerings, Type, Application & End-User (2020 – 2025)
Organ-on-a-chip Market Analysis by Offerings, Type, Application & End-User (2020 – 2025)
The Global Organ on a chip Market investigation report contains Types, Application & all logical and factual briefs about market Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like {playerNamesStr}
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global organ-on-a-chip market generated revenue of US$ 23.3 million in 2020 and is expected to reach US$ 116.7 million by 2025 with a CAGR of 38.0% in the forecast period. The study offers a detailed analysis of the global market for Organ-on-a-chip.
The advantages of organ-on-a-chip over cell culture, animal models, and human clinical trials have captured the attention of the medical and pharmaceutical communities focusing on developing targeted therapies. In May 2018, AstraZeneca partnered with Emulate, Inc. to develop ORGAN-ON-A-CHIP models to demonstrate the utility of this technology as a more predictive alternative for efficacy and safety testing of new chemical entities. In 2017, Roche collaborated with ETH Zurich and the Wyss Institute at Harvard to intensify its focus on OOC that can help in advancing human-based and personalized research and development of drugs.
Considering 2019 as the base year, the report provides projected market information for the 2020 to 2025 forecast period. The study includes information on the current size and projected growth of the overall organ-on-a-chip market and its associated business segments. Revenue estimates for this period segmented on the offerings, type, application, and end-user. It outlines the dynamics, the business environment, and emerging developments in the organ-on-a-chip market.
The organ-on-a-chip market report will help several vendors make the right investment and development decisions. The research focuses on the global organ-on-a-chip scenario and its proliferation across various market verticals. The descriptions in this report cover factors that currently influence and impede market growth and factor that will accelerate the future dimensions of demand for organ-on-a-chip.
The chapters included in the report describe leading players in the organ-on-a-chip market. The study provides landscape analysis, which offers detailed profiles of major players in the organ-on-a-chip market worldwide. The report covers a fine-grained taxonomy of market segmentation in terms of offerings, type, application, and end-user.
By Offerings
• Product
• Services
Based on offerings, the product segment holds the dominating position in the market in 2020 and is expected to retain its dominance throughout the forecast. The service segment is expected to grow with the highest CAGR in the forecast period.
By Type
• Liver
• Heart
• Kidney
• Lung
• Others
The liver segment holds the dominating position in the market in 2020 and is expected to retain its dominance throughout the forecast period. In concern with the changing lifestyle of peoples, all around the world, such as consumption of alcoholic drinks, junk food, animal flesh, and consuming various strong drugs, have resulted in increasing liver failures and various diseases that have harmful effects on the functionality of the liver. Thus, with an increase in liver diseases, demand for curing those diseases has also increased which accelerated the demand for liver-on-a-chip. The heart segment is expected to grow with the highest CAGR in the forecast period. Heart- and vasculature-on-a-chip platforms have been successfully generated, to study a variety of physiological phenomena, model diseases, and probe the effects of drugs.
By Application
• Toxicity Research
• Drug Discovery
• Physiological Model Development
The toxicity research application is expected to grow with the highest CAGR during the forecast period. A unique advantage of organ-on-a-chip is the ability to integrate drug metabolism and drug toxic processes in a single device, which facilitates the evaluation of the toxicity of drug metabolites. Human organ-on-a-chip has been fabricated and used to assess drug toxicity with data correlation with the clinical trial. Also, drug discovery holds a dominant market position in 2020 and is expected to remain dominant over the forecast period.
By End-User
• Academics and Research Institutes
• Pharmaceuticals & Biotechnology Companies
• Cosmetic Industry
• Others
The pharmaceuticals & biotechnology company segment is expected to grow with the highest CAGR during the forecast period. The pharmaceutical and biotechnology companies are adopting this technology to perform research and produce better drugs, in turn, providing a surge to the organ-on-a-chip market. Moreover, the academics segment holds the dominating position in the market in 2020 and is expected to retain its dominance throughout the forecast period. As the usage of this organ-on-a-chip technology is majorly based on the research of new treatments for all kinds of diseases known to the human body.
By Region
• North America
• Europe
• Asia Pacific
• Rest of World
North America is expected to contribute to the larger market share in 2020. The United States and Canada are the largest market-driven countries in this region. Owing to factors, such as the availability of a wide range of services offered by major players and an increase in toxicological testing of chemicals on the different types of organ cells. Huge investments are being made by the public and private institutes for their research. This has further increased the growth in the market studied. Moreover, Europe is projected to rise at the fastest CAGR in the forecast period. Germany, the U.K., and France are some of the major market-driven countries in this region. The availability of advanced interventional products (including organ-on-a-chip), and increasing drug discovery to provide better treatments, are driving market growth in European countries and thus providing market growth to the organ-on-a-chip market at a global scale.
Market Players
Some of the major players in the Organ-on-a-chip market are Ascendance Bio, Axosim, CN Bio, Emulate, Hurel, Insphero, Kirkstall, Mimetas, Nortis, Synvivo, Tissuse
1. Introduction
2. Market Overview
2.1. Global Organ-On-A-Chip Market Introduction
2.2. Macro- Economic Factor
2.3. Market Determinants
2.3.1. Market Driver
2.3.2. Market Restraints
2.3.3. Market Opportunities
2.3.4. Market Challenges
2.4. Value Chain Analysis
2.5. Technology/Product Roadmap
2.6. Porters 5 Force Model
2.7. Market Growth Opportunity Analysis
3. Market Segmentation
3.1. Global Organ-On-A-Chip Market Analysis (US$ Mn), By Offerings, 2019 - 2025
3.1.1. Product
3.1.2. Services
3.2. Global Organ-On-A-Chip Market Analysis (US$ Mn), By Type, 2019 - 2025
3.2.1. Liver
3.2.2. Heart
3.2.3. Kidney
3.2.4. Lung
3.2.5. Others
3.3. Global Organ-On-A-Chip Market Analysis (US$ Mn), By Application, 2019 – 2025
3.3.1. Toxicity Research
3.3.2. Drug Discovery
3.3.3. Physiological Model Development
3.4. Global Organ-On-A-Chip Market Analysis (US$ Mn), By End User, 2019 – 2025
3.4.1. Academics and Research Institutes
3.4.2. Pharmaceuticals & Biotechnology Companies
3.4.3. Cosmetic Industry
3.4.4. Others
4. Regional Analysis
4.1. North America Organ-On-A-Chip Market Analysis (US$ Mn), 2019 - 2025
4.1.1. By Country
4.1.1.1. U.S.
4.1.1.2. Canada
4.1.2. By Offerings
4.1.2.1. Product
4.1.2.2. Services
4.1.3. By Type
4.1.3.1. Liver
4.1.3.2. Heart
4.1.3.3. Kidney
4.1.3.4. Lung
4.1.3.5. Others
4.1.4. By Application
4.1.4.1. Toxicity Research
4.1.4.2. Drug Discovery
4.1.4.3. Physiological Model Development
4.1.5. By End User
4.1.5.1. Academics and Research Institutes
4.1.5.2. Pharmaceuticals & Biotechnology Companies
4.1.5.3. Cosmetic Industry
4.1.5.4. Others
4.2. Europe Organ-On-A-Chip Market Analysis (US$ Mn), 2019 - 2025
4.2.1. By Country, 2019 – 2025
4.2.1.1. Germany
4.2.1.2. U.K.
4.2.1.3. France
4.2.1.4. Italy
4.2.1.5. Spain
4.2.1.6. Rest of Europe
4.2.2. By Offerings
4.2.2.1. Product
4.2.2.2. Services
4.2.3. By Type
4.2.3.1. Liver
4.2.3.2. Heart
4.2.3.3. Kidney
4.2.3.4. Lung
4.2.3.5. Others
4.2.4. By Application
4.2.4.1. Toxicity Research
4.2.4.2. Drug Discovery
4.2.4.3. Physiological Model Development
4.2.5. By End User
4.2.5.1. Academics and Research Institutes
4.2.5.2. Pharmaceuticals & Biotechnology Companies
4.2.5.3. Cosmetic Industry
4.2.5.4. Others
4.3. Asia Pacific Organ-On-A-Chip Market Analysis (US$ Mn), 2019 - 2025
4.3.1. By Country, 2019 – 2025
4.3.1.1. China
4.3.1.2. Japan
4.3.1.3. India
4.3.1.4. Rest of Asia Pacific
4.3.2. By Offerings
4.3.2.1. Product
4.3.2.2. Services
4.3.3. By Type
4.3.3.1. Liver
4.3.3.2. Heart
4.3.3.3. Kidney
4.3.3.4. Lung
4.3.3.5. Others
4.3.4. By Application
4.3.4.1. Toxicity Research
4.3.4.2. Drug Discovery
4.3.4.3. Physiological Model Development
4.3.5. By End User
4.3.5.1. Academics and Research Institutes
4.3.5.2. Pharmaceuticals & Biotechnology Companies
4.3.5.3. Cosmetic Industry
4.3.5.4. Others
4.4. Rest of the world Organ-On-A-Chip Market Analysis (US$ Mn), 2019 - 2025
4.4.1. By Offerings
4.4.1.1. Product
4.4.1.2. Services
4.4.2. By Type
4.4.2.1. Liver
4.4.2.2. Heart
4.4.2.3. Kidney
4.4.2.4. Lung
4.4.2.5. Others
4.4.3. By Application
4.4.3.1. Toxicity Research
4.4.3.2. Drug Discovery
4.4.3.3. Physiological Model Development
4.4.4. By End User
4.4.4.1. Academics and Research Institutes
4.4.4.2. Pharmaceuticals & Biotechnology Companies
4.4.4.3. Cosmetic Industry
4.4.4.4. Others
5. Competitive Analysis
5.1. Company Share Analysis (%) 2019
5.2. List of Acquisition, Merger, Collaboration & New Product Launch
6. Company Profiles
6.1. Ascendance Bio
6.2. Axosim
6.3. CN Bio
6.4. Emulate
6.5. Hurel
6.6. Insphero
6.7. Kirkstall
6.8. Mimetas
6.9. Nortis
6.10. Synvivo
6.11. Tissuse
Research Methodology:
Organ on a chip Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|